Skip to main content

Table 1 Clinicopathological characteristics and follow-up data for 99 patients with BC

From: Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivotumor growth

Characteristics Number of patients/Number analyzed (%)
Median age (range) 48 (30 to 74) (years)
Histological type*  
   Ductal 93/99 (94%)
   Lobular 1/99 (1%)
   Other 5/99 (5%)
Histological grade*  
   I 22/99 (22%)
   II 58/99 (58%)
   III 19/99 (20%)
Lymph node status at time of primary diagnosis
   Metastasis 57/99 (58%)
   No metastasis 42/99 (42%)
AJCC clinical stage**  
   I 8/99 (8%)
   II 68/99 (69%)
   III 23/99 (23%)
Overall survival (median, range) 74 (6 to 112) (months)
   Alive without evidence of cancer 45/99 (68%)
   Alive with cancer 14/99 (14%)
   Died of cancer 40/99 (40%)
   Died of other disease 0/99 (0%)
  1. * According to the WHO classification of BC. ** According to the AJCC staging system; AJCC, American Joint Committee on Cancer; BC, breast cancer; WHO, World Health Organization.
\